JYOTHYLAB

Jyothy Labs Share Price

₹405.00 +0.25 (0.06%)

21 Nov, 2024 14:03

SIP TrendupStart SIP in JYOTHYLAB

Start SIP

Performance

  • Low
  • ₹395
  • High
  • ₹409
  • 52 Week Low
  • ₹367
  • 52 Week High
  • ₹596
  • Open Price₹405
  • Previous Close₹405
  • Volume612,058

Investment Returns

  • Over 1 Month -20.91%
  • Over 3 Month -28.15%
  • Over 6 Month -9.54%
  • Over 1 Year -9.68%
SIP Lightning

Smart Investing Starts Here Start SIP with Jyothy Labs for Steady Growth!

Invest Now

Jyothy Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39.6
  • PEG Ratio
  • 2.6
  • Market Cap Cr
  • 14,872
  • P/B Ratio
  • 8.2
  • Average True Range
  • 21.87
  • EPS
  • 10.23
  • Dividend Yield
  • 0.9
  • MACD Signal
  • -17.78
  • RSI
  • 21.84
  • MFI
  • 22.64

Jyothy Labs Financials

Jyothy Labs Technicals

EMA & SMA

Current Price
₹405.00
+ 0.25 (0.06%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹472.80
  • 50 Day
  • ₹500.04
  • 100 Day
  • ₹502.22
  • 200 Day
  • ₹478.15

Resistance and Support

408.88 Pivot Speed
  • R3 436.07
  • R2 428.38
  • R1 416.57
  • S1 397.07
  • S2 389.38
  • S3 377.57

What's your outlook on Jyothy Labs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Jyothy Labs Ltd. is a leading Indian FMCG company offering household products like detergents, dishwash liquids, mosquito repellents, and personal care items. It operates across India with popular brands like Ujala, Exo, Maxo, and Pril, serving millions of households.

Jyothy Labs has an operating revenue of Rs. 2,813.06 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 17% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 14 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 126 indicates it belongs to a poor industry group of Soap & Clng Preparatns and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Jyothy Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-07-25 Quarterly Results
2024-05-15 Audited Results & Final Dividend
2024-01-31 Quarterly Results
2023-11-07 Quarterly Results

Jyothy Labs F&O

Jyothy Labs Shareholding Pattern

62.89%
14.62%
0.5%
15.1%
0%
5.92%
0.97%

About Jyothy Labs

  • NSE Symbol
  • JYOTHYLAB
  • BSE Symbol
  • 532926
  • Chairperson & Managing Director
  • Ms. M R Jyothy
  • ISIN
  • INE668F01031

Similar Stocks to Jyothy Labs

Jyothy Labs FAQs

Jyothy Labs share price is ₹405 As on 21 November, 2024 | 13:49

The Market Cap of Jyothy Labs is ₹14871.9 Cr As on 21 November, 2024 | 13:49

The P/E ratio of Jyothy Labs is 39.6 As on 21 November, 2024 | 13:49

The PB ratio of Jyothy Labs is 8.2 As on 21 November, 2024 | 13:49

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23